Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
2 | 69.4 | -97.12% | 65.29 | -96.94% |
| P/S |
|
0.69 | 6.51 | -89.4% |
|
|
| P/BV |
|
0.89 | 3.96 | -77.5% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
0.53 | 11.85 | -95.53% |
|
|
| Ev/S |
|
0.2173 | 5.98 | -96.36% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.4932 | 0.0396 | 1145.64% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
10/10
|
41.62 | 16.34 | 154.7% | 50.46 | -17.52% |
| ROE |
|
54.26 | 11.95 | 354.22% |
|
|
| ROA |
|
30.95 | 5.4 | 472.97% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
34.32 | 16.23 | 111.43% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0617 | 14.63 | -99.58% | 0.0617 | 0% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.0758 | 3.6 | -97.89% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
18.68 | 1.83 | 919.1% | 3.16 | +490.42% |
| Number of years of dividend growth |
|
3 | 1.44 | 108.7% | ||
| DSI |
|
0.8571 | 0.9113 | -5.94% |
|
|
| Average dividend growth |
|
11.12 | 10.4 | 6.93% |
|
|
| Average percentage for 5 years |
|
3.16 | 1.14 | 177.03% |
|
|
| Average percentage for payments |
|
123.64 | 44.8 | 175.98% |
|
|
| Difference from average difference in sector |
|
16.85 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
313.75 | 61.43 | 410.74% | ||
| Growth impulse Ebitda in 5 years |
|
5989.5 | 158.62 | 3676.01% | ||
| Growth impulse Net Income in 5 years |
|
80.43 | 66.93 | 20.17% | ||
| Growth impulse FCF in 5 years |
|
-3089.15 | 248.41 | -1343.57% | ||
| Growth impulse EPS in 5 years |
|
911.73 | 73.29 | 1144% |
IP Score
8.47/10
